Muzafarova Sh.Sh

2 ta ish

Tashkent State Medical University, Tashkent, Uzbekistan

1. FEATURES OF THE IMPACT OF NOVEL GLUCOSE-LOWERING DRUG CLASSES ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

   Muzafarova Sh.Sh, Shagazatova B.Kh

   BoshqaZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.880269

2. FEATURES OF THE IMPACT OF NOVEL GLUCOSE-LOWERING DRUG CLASSES ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

   Muzafarova Sh.Sh, Shagazatova B.Kh

   BoshqaZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.880295